|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date11 Feb 2025 |
|
Mechanismγ-secretase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date27 Nov 2023 |
100 Clinical Results associated with SpringWorks Therapeutics Ireland Ltd.
0 Patents (Medical) associated with SpringWorks Therapeutics Ireland Ltd.
100 Deals associated with SpringWorks Therapeutics Ireland Ltd.
100 Translational Medicine associated with SpringWorks Therapeutics Ireland Ltd.